Sponsor or institution
Clinical trials and research at Kinea Bio, INC.
As of November 12, 2026, Find a Trial lists 5 NIH-funded research projects at this institution, with $3.6 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5NIH research projects
NIH-funded research (5)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Scalable non-viral gene delivery for a common muscular dystrophy
A patient-focused project tests a non-viral therapy to reduce harmful DMPK RNA in muscle because this could lessen symptoms of myotonic dystrophy type 1.
-
Split-Intein Gene Delivery to Treat Duchenne Muscular Dystrophy
A new gene therapy approach aims to deliver a larger, more functional dystrophin gene to heart and muscle cells in people with Duchenne muscular dystrophy.
-
Novel genetic medicine approach to treat orphan diseases with AAV vectors
A NIH-funded project is testing new ways to deliver large therapeutic genes using AAV vectors to help people with muscular dystrophies caused by big gene mutations.
-
New genetic treatments for rare diseases
This study is exploring a new way to use special viruses to deliver larger genes that can help treat rare muscle disorders, like dysferlinopathies, by combining two of these viruses to improve treatment outcomes for patients.
-
New genetic treatments for rare diseases using advanced viral vectors
This study is exploring new ways to use genetic medicine to help people with rare muscle diseases caused by gene mutations, aiming to deliver complete genes more effectively to improve treatment options for those affected.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.